nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—ulcerative colitis	0.329	1	CbGaD
Zafirlukast—PTGS1—Olsalazine—ulcerative colitis	0.0626	0.12	CbGbCtD
Zafirlukast—PTGS1—Balsalazide—ulcerative colitis	0.0558	0.107	CbGbCtD
Zafirlukast—PTGS1—Mesalazine—ulcerative colitis	0.0446	0.0855	CbGbCtD
Zafirlukast—ABCG2—Sulfasalazine—ulcerative colitis	0.027	0.0518	CbGbCtD
Zafirlukast—PTGS1—Sulfasalazine—ulcerative colitis	0.0249	0.0478	CbGbCtD
Zafirlukast—CYP2E1—Nicotine—ulcerative colitis	0.0248	0.0475	CbGbCtD
Zafirlukast—ABCG2—Hydrocortisone—ulcerative colitis	0.0217	0.0416	CbGbCtD
Zafirlukast—CYP2C8—Nicotine—ulcerative colitis	0.0185	0.0355	CbGbCtD
Zafirlukast—CYP3A4—Budesonide—ulcerative colitis	0.0172	0.033	CbGbCtD
Zafirlukast—CYP2C8—Cholecalciferol—ulcerative colitis	0.0166	0.0318	CbGbCtD
Zafirlukast—CYP2C19—Nicotine—ulcerative colitis	0.0155	0.0298	CbGbCtD
Zafirlukast—CYP1A2—Nicotine—ulcerative colitis	0.0143	0.0275	CbGbCtD
Zafirlukast—CYP2C19—Cholecalciferol—ulcerative colitis	0.0139	0.0267	CbGbCtD
Zafirlukast—ABCG2—Dexamethasone—ulcerative colitis	0.0135	0.0258	CbGbCtD
Zafirlukast—CYP2C9—Nicotine—ulcerative colitis	0.0129	0.0247	CbGbCtD
Zafirlukast—CYP2D6—Nicotine—ulcerative colitis	0.0118	0.0226	CbGbCtD
Zafirlukast—CYP2C9—Cholecalciferol—ulcerative colitis	0.0116	0.0222	CbGbCtD
Zafirlukast—CYP2C8—Hydrocortisone—ulcerative colitis	0.0115	0.0221	CbGbCtD
Zafirlukast—CYP2D6—Cholecalciferol—ulcerative colitis	0.0106	0.0203	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—ulcerative colitis	0.00965	0.0185	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—ulcerative colitis	0.00961	0.0184	CbGbCtD
Zafirlukast—CYP3A4—Methylprednisolone—ulcerative colitis	0.0077	0.0148	CbGbCtD
Zafirlukast—CYP3A4—Nicotine—ulcerative colitis	0.0075	0.0144	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—ulcerative colitis	0.00718	0.0138	CbGbCtD
Zafirlukast—CYP3A4—Cholecalciferol—ulcerative colitis	0.00673	0.0129	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—ulcerative colitis	0.00602	0.0115	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—ulcerative colitis	0.00583	0.0112	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—ulcerative colitis	0.00501	0.0096	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—ulcerative colitis	0.005	0.0096	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—ulcerative colitis	0.00494	0.00947	CbGbCtD
Zafirlukast—CYP3A4—Hydrocortisone—ulcerative colitis	0.00468	0.00898	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—ulcerative colitis	0.00466	0.00894	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—ulcerative colitis	0.00458	0.00878	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—ulcerative colitis	0.00291	0.00558	CbGbCtD
Zafirlukast—Tolvaptan—ABCB1—ulcerative colitis	0.000799	0.618	CrCbGaD
Zafirlukast—Glyburide—ALB—ulcerative colitis	0.000253	0.195	CrCbGaD
Zafirlukast—Glyburide—ABCB1—ulcerative colitis	0.000241	0.187	CrCbGaD
Zafirlukast—Discomfort—Mesalazine—ulcerative colitis	0.000198	0.00176	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisolone—ulcerative colitis	0.000198	0.00176	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000198	0.00176	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000198	0.00176	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisolone—ulcerative colitis	0.000197	0.00175	CcSEcCtD
Zafirlukast—Feeling abnormal—Budesonide—ulcerative colitis	0.000195	0.00173	CcSEcCtD
Zafirlukast—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000194	0.00172	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000193	0.00172	CcSEcCtD
Zafirlukast—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000193	0.00171	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000192	0.00171	CcSEcCtD
Zafirlukast—Oedema—Mesalazine—ulcerative colitis	0.000192	0.00171	CcSEcCtD
Zafirlukast—Infection—Mesalazine—ulcerative colitis	0.000191	0.0017	CcSEcCtD
Zafirlukast—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000188	0.00168	CcSEcCtD
Zafirlukast—Urticaria—Budesonide—ulcerative colitis	0.000188	0.00167	CcSEcCtD
Zafirlukast—Abdominal pain—Budesonide—ulcerative colitis	0.000187	0.00166	CcSEcCtD
Zafirlukast—Body temperature increased—Budesonide—ulcerative colitis	0.000187	0.00166	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000182	0.00162	CcSEcCtD
Zafirlukast—Haemoglobin—Triamcinolone—ulcerative colitis	0.000182	0.00162	CcSEcCtD
Zafirlukast—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000182	0.00162	CcSEcCtD
Zafirlukast—Haemorrhage—Triamcinolone—ulcerative colitis	0.000181	0.00161	CcSEcCtD
Zafirlukast—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000181	0.00161	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.00018	0.0016	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.00018	0.0016	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000175	0.00156	CcSEcCtD
Zafirlukast—Hypersensitivity—Budesonide—ulcerative colitis	0.000174	0.00155	CcSEcCtD
Zafirlukast—Feeling abnormal—Azathioprine—ulcerative colitis	0.000174	0.00155	CcSEcCtD
Zafirlukast—Insomnia—Mesalazine—ulcerative colitis	0.000174	0.00155	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000173	0.00154	CcSEcCtD
Zafirlukast—Asthenia—Budesonide—ulcerative colitis	0.00017	0.00151	CcSEcCtD
Zafirlukast—Dyspepsia—Mesalazine—ulcerative colitis	0.000169	0.00151	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—ulcerative colitis	0.000167	0.00149	CcSEcCtD
Zafirlukast—Pruritus—Budesonide—ulcerative colitis	0.000167	0.00149	CcSEcCtD
Zafirlukast—Body temperature increased—Azathioprine—ulcerative colitis	0.000167	0.00149	CcSEcCtD
Zafirlukast—Abdominal pain—Azathioprine—ulcerative colitis	0.000167	0.00149	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000166	0.00148	CcSEcCtD
Zafirlukast—Fatigue—Mesalazine—ulcerative colitis	0.000166	0.00148	CcSEcCtD
Zafirlukast—Haemoglobin—Dexamethasone—ulcerative colitis	0.000165	0.00147	CcSEcCtD
Zafirlukast—Haemoglobin—Betamethasone—ulcerative colitis	0.000165	0.00147	CcSEcCtD
Zafirlukast—Pain—Mesalazine—ulcerative colitis	0.000165	0.00146	CcSEcCtD
Zafirlukast—Haemorrhage—Dexamethasone—ulcerative colitis	0.000165	0.00146	CcSEcCtD
Zafirlukast—Haemorrhage—Betamethasone—ulcerative colitis	0.000165	0.00146	CcSEcCtD
Zafirlukast—Diarrhoea—Budesonide—ulcerative colitis	0.000162	0.00144	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000159	0.00142	CcSEcCtD
Zafirlukast—Feeling abnormal—Mesalazine—ulcerative colitis	0.000159	0.00141	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000157	0.0014	CcSEcCtD
Zafirlukast—Angioedema—Prednisolone—ulcerative colitis	0.000157	0.00139	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000156	0.00139	CcSEcCtD
Zafirlukast—Dizziness—Budesonide—ulcerative colitis	0.000156	0.00139	CcSEcCtD
Zafirlukast—Hypersensitivity—Azathioprine—ulcerative colitis	0.000156	0.00138	CcSEcCtD
Zafirlukast—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000156	0.00138	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—ulcerative colitis	0.000155	0.00138	CcSEcCtD
Zafirlukast—Angioedema—Hydrocortisone—ulcerative colitis	0.000153	0.00136	CcSEcCtD
Zafirlukast—Urticaria—Mesalazine—ulcerative colitis	0.000153	0.00136	CcSEcCtD
Zafirlukast—Back pain—Triamcinolone—ulcerative colitis	0.000153	0.00136	CcSEcCtD
Zafirlukast—Abdominal pain—Mesalazine—ulcerative colitis	0.000152	0.00135	CcSEcCtD
Zafirlukast—Body temperature increased—Mesalazine—ulcerative colitis	0.000152	0.00135	CcSEcCtD
Zafirlukast—Malaise—Hydrocortisone—ulcerative colitis	0.000151	0.00134	CcSEcCtD
Zafirlukast—Vomiting—Budesonide—ulcerative colitis	0.00015	0.00134	CcSEcCtD
Zafirlukast—Rash—Budesonide—ulcerative colitis	0.000149	0.00133	CcSEcCtD
Zafirlukast—Dermatitis—Budesonide—ulcerative colitis	0.000149	0.00133	CcSEcCtD
Zafirlukast—Headache—Budesonide—ulcerative colitis	0.000148	0.00132	CcSEcCtD
Zafirlukast—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000146	0.0013	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000146	0.0013	CcSEcCtD
Zafirlukast—Diarrhoea—Azathioprine—ulcerative colitis	0.000145	0.00129	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—ulcerative colitis	0.000144	0.00128	CcSEcCtD
Zafirlukast—Angioedema—Triamcinolone—ulcerative colitis	0.000144	0.00128	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—ulcerative colitis	0.000144	0.00128	CcSEcCtD
Zafirlukast—Angioedema—Methylprednisolone—ulcerative colitis	0.000144	0.00128	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—ulcerative colitis	0.000143	0.00127	CcSEcCtD
Zafirlukast—Myalgia—Hydrocortisone—ulcerative colitis	0.000143	0.00127	CcSEcCtD
Zafirlukast—Malaise—Triamcinolone—ulcerative colitis	0.000142	0.00127	CcSEcCtD
Zafirlukast—Malaise—Methylprednisolone—ulcerative colitis	0.000142	0.00126	CcSEcCtD
Zafirlukast—Hypersensitivity—Mesalazine—ulcerative colitis	0.000142	0.00126	CcSEcCtD
Zafirlukast—Discomfort—Hydrocortisone—ulcerative colitis	0.000141	0.00125	CcSEcCtD
Zafirlukast—Nausea—Budesonide—ulcerative colitis	0.000141	0.00125	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—ulcerative colitis	0.00014	0.00125	CcSEcCtD
Zafirlukast—Dizziness—Azathioprine—ulcerative colitis	0.00014	0.00124	CcSEcCtD
Zafirlukast—Asthenia—Mesalazine—ulcerative colitis	0.000138	0.00123	CcSEcCtD
Zafirlukast—Oedema—Hydrocortisone—ulcerative colitis	0.000137	0.00122	CcSEcCtD
Zafirlukast—Pruritus—Mesalazine—ulcerative colitis	0.000136	0.00121	CcSEcCtD
Zafirlukast—Infection—Hydrocortisone—ulcerative colitis	0.000136	0.00121	CcSEcCtD
Zafirlukast—Myalgia—Triamcinolone—ulcerative colitis	0.000134	0.0012	CcSEcCtD
Zafirlukast—Vomiting—Azathioprine—ulcerative colitis	0.000134	0.00119	CcSEcCtD
Zafirlukast—Arthralgia—Methylprednisolone—ulcerative colitis	0.000134	0.00119	CcSEcCtD
Zafirlukast—Myalgia—Methylprednisolone—ulcerative colitis	0.000134	0.00119	CcSEcCtD
Zafirlukast—Rash—Azathioprine—ulcerative colitis	0.000133	0.00118	CcSEcCtD
Zafirlukast—Dermatitis—Azathioprine—ulcerative colitis	0.000133	0.00118	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000133	0.00118	CcSEcCtD
Zafirlukast—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000133	0.00118	CcSEcCtD
Zafirlukast—Discomfort—Triamcinolone—ulcerative colitis	0.000133	0.00118	CcSEcCtD
Zafirlukast—Discomfort—Methylprednisolone—ulcerative colitis	0.000132	0.00118	CcSEcCtD
Zafirlukast—Headache—Azathioprine—ulcerative colitis	0.000132	0.00118	CcSEcCtD
Zafirlukast—Diarrhoea—Mesalazine—ulcerative colitis	0.000132	0.00117	CcSEcCtD
Zafirlukast—Angioedema—Dexamethasone—ulcerative colitis	0.000131	0.00116	CcSEcCtD
Zafirlukast—Angioedema—Betamethasone—ulcerative colitis	0.000131	0.00116	CcSEcCtD
Zafirlukast—Malaise—Betamethasone—ulcerative colitis	0.000129	0.00115	CcSEcCtD
Zafirlukast—Malaise—Dexamethasone—ulcerative colitis	0.000129	0.00115	CcSEcCtD
Zafirlukast—Oedema—Triamcinolone—ulcerative colitis	0.000129	0.00115	CcSEcCtD
Zafirlukast—Infection—Triamcinolone—ulcerative colitis	0.000128	0.00114	CcSEcCtD
Zafirlukast—Infection—Methylprednisolone—ulcerative colitis	0.000128	0.00114	CcSEcCtD
Zafirlukast—Dizziness—Mesalazine—ulcerative colitis	0.000127	0.00113	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—ulcerative colitis	0.000127	0.00113	CcSEcCtD
Zafirlukast—Nausea—Azathioprine—ulcerative colitis	0.000125	0.00112	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000125	0.00111	CcSEcCtD
Zafirlukast—Insomnia—Hydrocortisone—ulcerative colitis	0.000124	0.0011	CcSEcCtD
Zafirlukast—Vomiting—Mesalazine—ulcerative colitis	0.000122	0.00109	CcSEcCtD
Zafirlukast—Myalgia—Betamethasone—ulcerative colitis	0.000122	0.00108	CcSEcCtD
Zafirlukast—Myalgia—Dexamethasone—ulcerative colitis	0.000122	0.00108	CcSEcCtD
Zafirlukast—Rash—Mesalazine—ulcerative colitis	0.000121	0.00108	CcSEcCtD
Zafirlukast—Dermatitis—Mesalazine—ulcerative colitis	0.000121	0.00108	CcSEcCtD
Zafirlukast—Headache—Mesalazine—ulcerative colitis	0.000121	0.00107	CcSEcCtD
Zafirlukast—Discomfort—Betamethasone—ulcerative colitis	0.00012	0.00107	CcSEcCtD
Zafirlukast—Discomfort—Dexamethasone—ulcerative colitis	0.00012	0.00107	CcSEcCtD
Zafirlukast—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00012	0.00107	CcSEcCtD
Zafirlukast—Pain—Prednisolone—ulcerative colitis	0.00012	0.00107	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000118	0.00105	CcSEcCtD
Zafirlukast—Fatigue—Hydrocortisone—ulcerative colitis	0.000118	0.00105	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Pain—Hydrocortisone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Oedema—Betamethasone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Oedema—Dexamethasone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Insomnia—Triamcinolone—ulcerative colitis	0.000117	0.00104	CcSEcCtD
Zafirlukast—Insomnia—Methylprednisolone—ulcerative colitis	0.000116	0.00103	CcSEcCtD
Zafirlukast—Infection—Betamethasone—ulcerative colitis	0.000116	0.00103	CcSEcCtD
Zafirlukast—Infection—Dexamethasone—ulcerative colitis	0.000116	0.00103	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—ulcerative colitis	0.000116	0.00103	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—ulcerative colitis	0.000115	0.00103	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000114	0.00102	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000114	0.00102	CcSEcCtD
Zafirlukast—Nausea—Mesalazine—ulcerative colitis	0.000114	0.00102	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—ulcerative colitis	0.000114	0.00101	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—ulcerative colitis	0.000113	0.00101	CcSEcCtD
Zafirlukast—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000113	0.00101	CcSEcCtD
Zafirlukast—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000113	0.001	CcSEcCtD
Zafirlukast—Malaise—Prednisone—ulcerative colitis	0.000112	0.001	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000112	0.000995	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—ulcerative colitis	0.000111	0.00099	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—ulcerative colitis	0.000111	0.000988	CcSEcCtD
Zafirlukast—Fatigue—Methylprednisolone—ulcerative colitis	0.000111	0.000986	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—ulcerative colitis	0.00011	0.00098	CcSEcCtD
Zafirlukast—Urticaria—Hydrocortisone—ulcerative colitis	0.000109	0.000967	CcSEcCtD
Zafirlukast—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000108	0.000962	CcSEcCtD
Zafirlukast—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000108	0.000962	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000106	0.000947	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000106	0.000947	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—ulcerative colitis	0.000106	0.000944	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—ulcerative colitis	0.000106	0.000944	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000106	0.000944	CcSEcCtD
Zafirlukast—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000106	0.000942	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—ulcerative colitis	0.000106	0.00094	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—ulcerative colitis	0.000106	0.00094	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000105	0.000935	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—ulcerative colitis	0.000105	0.000933	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—ulcerative colitis	0.000103	0.000918	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—ulcerative colitis	0.000103	0.000915	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—ulcerative colitis	0.000103	0.000915	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—ulcerative colitis	0.000102	0.00091	CcSEcCtD
Zafirlukast—Urticaria—Methylprednisolone—ulcerative colitis	0.000102	0.000908	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—ulcerative colitis	0.000102	0.000906	CcSEcCtD
Zafirlukast—Oedema—Prednisone—ulcerative colitis	0.000102	0.000905	CcSEcCtD
Zafirlukast—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000102	0.000904	CcSEcCtD
Zafirlukast—Infection—Prednisone—ulcerative colitis	0.000101	0.000899	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000101	0.000898	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000101	0.000898	CcSEcCtD
Zafirlukast—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000101	0.000897	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—ulcerative colitis	0.000101	0.000896	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—ulcerative colitis	0.000101	0.000896	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—ulcerative colitis	0.0001	0.000889	CcSEcCtD
Zafirlukast—Pain—Betamethasone—ulcerative colitis	0.0001	0.000889	CcSEcCtD
Zafirlukast—Asthenia—Hydrocortisone—ulcerative colitis	9.82e-05	0.000873	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR6—ulcerative colitis	9.79e-05	0.00272	CbGpPWpGaD
Zafirlukast—Pruritus—Hydrocortisone—ulcerative colitis	9.68e-05	0.000861	CcSEcCtD
Zafirlukast—Feeling abnormal—Betamethasone—ulcerative colitis	9.63e-05	0.000857	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—ulcerative colitis	9.63e-05	0.000857	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.56e-05	0.00085	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.56e-05	0.00085	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—SEL1L—ulcerative colitis	9.55e-05	0.00265	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PTGER4—ulcerative colitis	9.49e-05	0.00263	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Triamcinolone—ulcerative colitis	9.49e-05	0.000844	CcSEcCtD
Zafirlukast—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.47e-05	0.000842	CcSEcCtD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	9.4e-05	0.00261	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	9.38e-05	0.0026	CbGpPWpGaD
Zafirlukast—Diarrhoea—Hydrocortisone—ulcerative colitis	9.36e-05	0.000833	CcSEcCtD
Zafirlukast—Urticaria—Dexamethasone—ulcerative colitis	9.29e-05	0.000826	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—ulcerative colitis	9.29e-05	0.000826	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.27e-05	0.000825	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—ulcerative colitis	9.26e-05	0.000824	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—ulcerative colitis	9.24e-05	0.000822	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—ulcerative colitis	9.24e-05	0.000822	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—ulcerative colitis	9.24e-05	0.000822	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—ulcerative colitis	9.24e-05	0.000822	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—ulcerative colitis	9.24e-05	0.000822	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR1—ulcerative colitis	9.23e-05	0.00256	CbGpPWpGaD
Zafirlukast—Asthenia—Methylprednisolone—ulcerative colitis	9.22e-05	0.00082	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—ulcerative colitis	9.21e-05	0.000819	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—ulcerative colitis	9.11e-05	0.000811	CcSEcCtD
Zafirlukast—Pruritus—Methylprednisolone—ulcerative colitis	9.09e-05	0.000809	CcSEcCtD
Zafirlukast—Dizziness—Hydrocortisone—ulcerative colitis	9.05e-05	0.000805	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—ulcerative colitis	8.96e-05	0.000797	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCL20—ulcerative colitis	8.92e-05	0.00247	CbGpPWpGaD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.87e-05	0.00246	CbGpPWpGaD
Zafirlukast—Rash—Prednisolone—ulcerative colitis	8.83e-05	0.000786	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR ligand binding—ADRB2—ulcerative colitis	8.82e-05	0.00245	CbGpPWpGaD
Zafirlukast—Dermatitis—Prednisolone—ulcerative colitis	8.82e-05	0.000785	CcSEcCtD
Zafirlukast—Diarrhoea—Methylprednisolone—ulcerative colitis	8.79e-05	0.000782	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—ulcerative colitis	8.78e-05	0.000781	CcSEcCtD
Zafirlukast—Headache—Prednisolone—ulcerative colitis	8.78e-05	0.000781	CcSEcCtD
Zafirlukast—Vomiting—Hydrocortisone—ulcerative colitis	8.7e-05	0.000774	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—GHRL—ulcerative colitis	8.69e-05	0.00241	CbGpPWpGaD
Zafirlukast—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	8.66e-05	0.0024	CbGpPWpGaD
Zafirlukast—Rash—Hydrocortisone—ulcerative colitis	8.63e-05	0.000767	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTGER4—ulcerative colitis	8.62e-05	0.00239	CbGpPWpGaD
Zafirlukast—Dermatitis—Hydrocortisone—ulcerative colitis	8.62e-05	0.000767	CcSEcCtD
Zafirlukast—Headache—Hydrocortisone—ulcerative colitis	8.57e-05	0.000762	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—ulcerative colitis	8.52e-05	0.000758	CcSEcCtD
Zafirlukast—Dizziness—Methylprednisolone—ulcerative colitis	8.5e-05	0.000756	CcSEcCtD
Zafirlukast—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	8.41e-05	0.00233	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Prednisone—ulcerative colitis	8.39e-05	0.000746	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—ulcerative colitis	8.39e-05	0.000746	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—ulcerative colitis	8.39e-05	0.000746	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GNA12—ulcerative colitis	8.39e-05	0.00233	CbGpPWpGaD
Zafirlukast—Gastrointestinal pain—Prednisone—ulcerative colitis	8.32e-05	0.00074	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—ulcerative colitis	8.32e-05	0.00074	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	8.28e-05	0.0023	CbGpPWpGaD
Zafirlukast—Pruritus—Dexamethasone—ulcerative colitis	8.27e-05	0.000736	CcSEcCtD
Zafirlukast—Pruritus—Betamethasone—ulcerative colitis	8.27e-05	0.000736	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—ulcerative colitis	8.19e-05	0.000729	CcSEcCtD
Zafirlukast—Vomiting—Methylprednisolone—ulcerative colitis	8.17e-05	0.000727	CcSEcCtD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.16e-05	0.00226	CbGpPWpGaD
Zafirlukast—Nausea—Hydrocortisone—ulcerative colitis	8.13e-05	0.000723	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—ulcerative colitis	8.12e-05	0.000722	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—ulcerative colitis	8.12e-05	0.000722	CcSEcCtD
Zafirlukast—Rash—Methylprednisolone—ulcerative colitis	8.1e-05	0.000721	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL20—ulcerative colitis	8.1e-05	0.00225	CbGpPWpGaD
Zafirlukast—Dermatitis—Methylprednisolone—ulcerative colitis	8.1e-05	0.00072	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—ulcerative colitis	8.09e-05	0.000719	CcSEcCtD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.09e-05	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	8.07e-05	0.00224	CbGpPWpGaD
Zafirlukast—Headache—Triamcinolone—ulcerative colitis	8.07e-05	0.000718	CcSEcCtD
Zafirlukast—Headache—Methylprednisolone—ulcerative colitis	8.05e-05	0.000716	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—ulcerative colitis	8.05e-05	0.000716	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—ulcerative colitis	8.05e-05	0.000716	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—ulcerative colitis	8e-05	0.000711	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—ulcerative colitis	8e-05	0.000711	CcSEcCtD
Zafirlukast—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	7.98e-05	0.00221	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	7.95e-05	0.00221	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—GHRL—ulcerative colitis	7.89e-05	0.00219	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR1—ulcerative colitis	7.86e-05	0.00218	CbGpPWpGaD
Zafirlukast—Dizziness—Betamethasone—ulcerative colitis	7.73e-05	0.000687	CcSEcCtD
Zafirlukast—Dizziness—Dexamethasone—ulcerative colitis	7.73e-05	0.000687	CcSEcCtD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.65e-05	0.00212	CbGpPWpGaD
Zafirlukast—Nausea—Triamcinolone—ulcerative colitis	7.65e-05	0.000681	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CALM3—ulcerative colitis	7.64e-05	0.00212	CbGpPWpGaD
Zafirlukast—Nausea—Methylprednisolone—ulcerative colitis	7.63e-05	0.000679	CcSEcCtD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	7.62e-05	0.00211	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GNA12—ulcerative colitis	7.62e-05	0.00211	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Prednisone—ulcerative colitis	7.5e-05	0.000667	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR6—ulcerative colitis	7.47e-05	0.00207	CbGpPWpGaD
Zafirlukast—Vomiting—Dexamethasone—ulcerative colitis	7.43e-05	0.000661	CcSEcCtD
Zafirlukast—Vomiting—Betamethasone—ulcerative colitis	7.43e-05	0.000661	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—ulcerative colitis	7.37e-05	0.000656	CcSEcCtD
Zafirlukast—Rash—Betamethasone—ulcerative colitis	7.37e-05	0.000656	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—ulcerative colitis	7.36e-05	0.000655	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—ulcerative colitis	7.36e-05	0.000655	CcSEcCtD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	7.34e-05	0.00204	CbGpPWpGaD
Zafirlukast—Headache—Betamethasone—ulcerative colitis	7.32e-05	0.000651	CcSEcCtD
Zafirlukast—Headache—Dexamethasone—ulcerative colitis	7.32e-05	0.000651	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—ulcerative colitis	7.3e-05	0.00065	CcSEcCtD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	7.27e-05	0.00202	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.26e-05	0.00201	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.24e-05	0.00201	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR2—ulcerative colitis	7.22e-05	0.002	CbGpPWpGaD
Zafirlukast—Pruritus—Prednisone—ulcerative colitis	7.2e-05	0.000641	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADRB2—ulcerative colitis	7.19e-05	0.002	CbGpPWpGaD
Zafirlukast—Diarrhoea—Prednisone—ulcerative colitis	6.96e-05	0.000619	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—ulcerative colitis	6.94e-05	0.000618	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—ulcerative colitis	6.94e-05	0.000618	CcSEcCtD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.91e-05	0.00192	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL20—ulcerative colitis	6.9e-05	0.00192	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR6—ulcerative colitis	6.79e-05	0.00188	CbGpPWpGaD
Zafirlukast—Dizziness—Prednisone—ulcerative colitis	6.73e-05	0.000599	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling Pathways—SEL1L—ulcerative colitis	6.62e-05	0.00184	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	6.58e-05	0.00183	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.54e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADRB2—ulcerative colitis	6.53e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	6.51e-05	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GNA12—ulcerative colitis	6.49e-05	0.0018	CbGpPWpGaD
Zafirlukast—Vomiting—Prednisone—ulcerative colitis	6.47e-05	0.000576	CcSEcCtD
Zafirlukast—Rash—Prednisone—ulcerative colitis	6.42e-05	0.000571	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—ulcerative colitis	6.41e-05	0.00057	CcSEcCtD
Zafirlukast—Headache—Prednisone—ulcerative colitis	6.38e-05	0.000567	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR2—ulcerative colitis	6.15e-05	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL8—ulcerative colitis	6.15e-05	0.00171	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	6.13e-05	0.0017	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	6.12e-05	0.0017	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—ADCY5—ulcerative colitis	6.11e-05	0.00169	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—PTGS1—ulcerative colitis	6.11e-05	0.00169	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	6.07e-05	0.00168	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	6.07e-05	0.00168	CbGpPWpGaD
Zafirlukast—Nausea—Prednisone—ulcerative colitis	6.05e-05	0.000538	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GHRL—ulcerative colitis	6.02e-05	0.00167	CbGpPWpGaD
Zafirlukast—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.99e-05	0.00166	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTGER4—ulcerative colitis	5.98e-05	0.00166	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR6—ulcerative colitis	5.78e-05	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.6e-05	0.00155	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.58e-05	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—ADCY5—ulcerative colitis	5.55e-05	0.00154	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	5.51e-05	0.00153	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAML2—ulcerative colitis	5.48e-05	0.00152	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GHRL—ulcerative colitis	5.47e-05	0.00152	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR1—ulcerative colitis	5.45e-05	0.00151	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.43e-05	0.00151	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	5.35e-05	0.00149	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.33e-05	0.00148	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CALM3—ulcerative colitis	5.3e-05	0.00147	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	5.28e-05	0.00146	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTGER4—ulcerative colitis	5.09e-05	0.00141	CbGpPWpGaD
Zafirlukast—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.07e-05	0.00141	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.05e-05	0.0014	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	4.99e-05	0.00138	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.98e-05	0.00138	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.85e-05	0.00135	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL20—ulcerative colitis	4.78e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	4.71e-05	0.00131	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GHRL—ulcerative colitis	4.66e-05	0.00129	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.65e-05	0.00129	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADRB2—ulcerative colitis	4.53e-05	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CALM3—ulcerative colitis	4.52e-05	0.00125	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GNA12—ulcerative colitis	4.5e-05	0.00125	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RIPK2—ulcerative colitis	4.45e-05	0.00123	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.42e-05	0.00123	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	4.33e-05	0.0012	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	4.3e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR2—ulcerative colitis	4.26e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL8—ulcerative colitis	4.26e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.25e-05	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	4.23e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	4.21e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	4.16e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	4.04e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR6—ulcerative colitis	4.01e-05	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADRB2—ulcerative colitis	3.86e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—ADCY5—ulcerative colitis	3.84e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—JAK2—ulcerative colitis	3.81e-05	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAML2—ulcerative colitis	3.8e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.78e-05	0.00105	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.78e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.76e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.74e-05	0.00104	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	3.67e-05	0.00102	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	3.61e-05	0.001	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTGER4—ulcerative colitis	3.53e-05	0.000979	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	3.51e-05	0.000973	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CHP1—ulcerative colitis	3.48e-05	0.000967	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL8—ulcerative colitis	3.47e-05	0.000964	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—JAK2—ulcerative colitis	3.46e-05	0.000959	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CHP1—ulcerative colitis	3.35e-05	0.000929	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—ulcerative colitis	3.32e-05	0.000921	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ADCY5—ulcerative colitis	3.28e-05	0.000909	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GHRL—ulcerative colitis	3.23e-05	0.000897	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL8—ulcerative colitis	3.16e-05	0.000876	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CALM3—ulcerative colitis	3.13e-05	0.000869	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RIPK2—ulcerative colitis	3.08e-05	0.000855	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—ulcerative colitis	3.02e-05	0.000837	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—DLD—ulcerative colitis	3.01e-05	0.000835	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.92e-05	0.00081	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.92e-05	0.000809	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—DLD—ulcerative colitis	2.89e-05	0.000802	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.83e-05	0.000786	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.73e-05	0.000757	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.73e-05	0.000757	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADRB2—ulcerative colitis	2.68e-05	0.000742	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—JAK2—ulcerative colitis	2.64e-05	0.000732	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CHP1—ulcerative colitis	2.5e-05	0.000694	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.41e-05	0.000668	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—JAK2—ulcerative colitis	2.4e-05	0.000665	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—ulcerative colitis	2.3e-05	0.000639	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ADCY5—ulcerative colitis	2.27e-05	0.00063	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL8—ulcerative colitis	2.19e-05	0.000607	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.17e-05	0.000603	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHP1—ulcerative colitis	2.16e-05	0.0006	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—DLD—ulcerative colitis	2.16e-05	0.000599	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—ulcerative colitis	2.09e-05	0.00058	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—JAK2—ulcerative colitis	2.04e-05	0.000567	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.03e-05	0.000563	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.03e-05	0.000562	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RELA—ulcerative colitis	1.98e-05	0.000549	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.93e-05	0.000536	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—DLD—ulcerative colitis	1.87e-05	0.000518	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL8—ulcerative colitis	1.86e-05	0.000517	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.81e-05	0.000502	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—ulcerative colitis	1.78e-05	0.000494	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.78e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—ulcerative colitis	1.77e-05	0.000492	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.76e-05	0.000488	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—ulcerative colitis	1.69e-05	0.000468	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NFKB1—ulcerative colitis	1.67e-05	0.000463	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—DLD—ulcerative colitis	1.67e-05	0.000462	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.65e-05	0.000458	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—DLD—ulcerative colitis	1.53e-05	0.000425	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.53e-05	0.000424	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—DLD—ulcerative colitis	1.52e-05	0.000422	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.5e-05	0.000417	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—ulcerative colitis	1.5e-05	0.000416	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.45e-05	0.000404	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—JAK2—ulcerative colitis	1.42e-05	0.000393	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.41e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—ulcerative colitis	1.39e-05	0.000386	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.37e-05	0.000381	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RELA—ulcerative colitis	1.37e-05	0.00038	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.36e-05	0.000377	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CALM3—ulcerative colitis	1.31e-05	0.000363	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—DLD—ulcerative colitis	1.3e-05	0.00036	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—ulcerative colitis	1.29e-05	0.000359	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CALM3—ulcerative colitis	1.26e-05	0.000349	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—ulcerative colitis	1.23e-05	0.000343	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—ulcerative colitis	1.23e-05	0.000341	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.2e-05	0.000334	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—ulcerative colitis	1.17e-05	0.000324	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.16e-05	0.000322	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NFKB1—ulcerative colitis	1.16e-05	0.000321	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—ulcerative colitis	1.14e-05	0.000317	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—ulcerative colitis	1.05e-05	0.000291	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS1—ulcerative colitis	1.04e-05	0.00029	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—ulcerative colitis	1.04e-05	0.000288	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—ulcerative colitis	1.02e-05	0.000283	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DLD—ulcerative colitis	1e-05	0.000278	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.87e-06	0.000274	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—ulcerative colitis	9.78e-06	0.000271	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—ulcerative colitis	9.63e-06	0.000267	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ADCY5—ulcerative colitis	9.5e-06	0.000264	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CALM3—ulcerative colitis	9.4e-06	0.000261	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ADCY5—ulcerative colitis	9.13e-06	0.000253	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS1—ulcerative colitis	9.03e-06	0.00025	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.88e-06	0.000246	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.81e-06	0.000245	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CALM3—ulcerative colitis	8.13e-06	0.000225	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS1—ulcerative colitis	8.06e-06	0.000224	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.03e-06	0.000223	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—ulcerative colitis	7.93e-06	0.00022	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.92e-06	0.00022	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.77e-06	0.000215	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS1—ulcerative colitis	7.41e-06	0.000206	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS1—ulcerative colitis	7.35e-06	0.000204	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—ulcerative colitis	7.31e-06	0.000203	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—ulcerative colitis	7.26e-06	0.000201	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CALM3—ulcerative colitis	7.25e-06	0.000201	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.22e-06	0.0002	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—ulcerative colitis	7.08e-06	0.000197	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.93e-06	0.000192	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.87e-06	0.000191	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADCY5—ulcerative colitis	6.82e-06	0.000189	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—ulcerative colitis	6.81e-06	0.000189	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CALM3—ulcerative colitis	6.67e-06	0.000185	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CALM3—ulcerative colitis	6.61e-06	0.000184	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—ulcerative colitis	6.37e-06	0.000177	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.32e-06	0.000175	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—ulcerative colitis	6.32e-06	0.000175	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS1—ulcerative colitis	6.28e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.17e-06	0.000171	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—ulcerative colitis	6.12e-06	0.00017	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADCY5—ulcerative colitis	5.9e-06	0.000164	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CALM3—ulcerative colitis	5.65e-06	0.000157	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—ulcerative colitis	5.64e-06	0.000157	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—ulcerative colitis	5.57e-06	0.000155	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.4e-06	0.00015	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—ulcerative colitis	5.35e-06	0.000149	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADCY5—ulcerative colitis	5.26e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.19e-06	0.000144	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—ulcerative colitis	5.14e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—ulcerative colitis	5.09e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.84e-06	0.000134	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADCY5—ulcerative colitis	4.84e-06	0.000134	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADCY5—ulcerative colitis	4.8e-06	0.000133	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—ulcerative colitis	4.57e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—ulcerative colitis	4.4e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—ulcerative colitis	4.4e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.36e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADCY5—ulcerative colitis	4.1e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—ulcerative colitis	4e-06	0.000111	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—ulcerative colitis	3.95e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.92e-06	0.000109	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.61e-06	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—ulcerative colitis	3.58e-06	9.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—ulcerative colitis	3.53e-06	9.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—ulcerative colitis	3.46e-06	9.6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.39e-06	9.41e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—ulcerative colitis	3.25e-06	9.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—ulcerative colitis	3.22e-06	8.93e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.16e-06	8.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—ulcerative colitis	3.09e-06	8.57e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—ulcerative colitis	3.06e-06	8.48e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.84e-06	7.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.81e-06	7.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—ulcerative colitis	2.75e-06	7.63e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.41e-06	6.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.36e-06	6.55e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—ulcerative colitis	2.12e-06	5.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.86e-06	5.15e-05	CbGpPWpGaD
